265 related articles for article (PubMed ID: 8832375)
1. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
2. Computed three-dimensional structures for the ras-binding domain of the raf-p74 protein complexed with ras-p21 and with its suppressor protein, rap-1A.
Chen JM; Manolatos S; Brandt-Rauf PW; Murphy RB; Monaco R; Pincus MR
J Protein Chem; 1996 Aug; 15(6):511-8. PubMed ID: 8895097
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the three-dimensional structure of the rap-1A protein from its homology to the ras-gene-encoded p21 protein.
Chen JM; Grad R; Monaco R; Pincus MR
J Protein Chem; 1996 Jan; 15(1):11-5. PubMed ID: 8838585
[TBL] [Abstract][Full Text] [Related]
4. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
[TBL] [Abstract][Full Text] [Related]
6. Amino acid 61 is a determinant of sensitivity of rap proteins to the ras GTPase activating protein.
Hart PA; Marshall CJ
Oncogene; 1990 Jul; 5(7):1099-101. PubMed ID: 2115644
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1A, bound to the ras-binding domain of the raf-p74 protein: identification of effector domains in the raf protein.
Chen JM; Monaco R; Manolatos S; Brandt-Rauf PW; Friedman FK; Pincus MR
J Protein Chem; 1997 Aug; 16(6):619-29. PubMed ID: 9263124
[TBL] [Abstract][Full Text] [Related]
8. Activated conformations of the ras-gene-encoded p21 protein. 2. Comparison of the computed and high-resolution x-ray crystallographic structures of Gly-12 p21.
Dykes DC; Brandt-Rauf P; Luster SM; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1993 Apr; 10(5):905-18. PubMed ID: 8318164
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes.
Zeng J; Treutlein HR; Simonson T
Proteins; 1999 Apr; 35(1):89-100. PubMed ID: 10090289
[TBL] [Abstract][Full Text] [Related]
10. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
[TBL] [Abstract][Full Text] [Related]
11. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling.
Chen JM; Rijhwani K; Friedman FK; Hyde MJ; Pincus MR
J Protein Chem; 2000 Oct; 19(7):545-51. PubMed ID: 11233167
[TBL] [Abstract][Full Text] [Related]
12. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
[TBL] [Abstract][Full Text] [Related]
13. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
Chen JM; Friedman FK; Brandt-Rauf PW; Pincus MR; Chie L
J Protein Chem; 2002 Jul; 21(5):349-59. PubMed ID: 12206509
[TBL] [Abstract][Full Text] [Related]
15. The molecular heterogeneity of the smg-21/Krev-1/rap1 proteins, a GTP-binding protein having the same effector domain as ras p21s, in bovine aortic smooth muscle membranes.
Kawata M; Kawahara Y; Sunako M; Araki S; Koide M; Tsuda T; Fukuzaki H; Takai Y
Oncogene; 1991 May; 6(5):841-8. PubMed ID: 1646988
[TBL] [Abstract][Full Text] [Related]
16. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.
Nassar N; Horn G; Herrmann C; Scherer A; McCormick F; Wittinghofer A
Nature; 1995 Jun; 375(6532):554-60. PubMed ID: 7791872
[TBL] [Abstract][Full Text] [Related]
17. Studies on the structure and mechanism of H-ras p21.
Goody RS; Pai EF; Schlichting I; Rensland H; Scheidig A; Franken S; Wittinghofer A
Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):3-10; discussion 10-1. PubMed ID: 1351293
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics of the H-ras gene-encoded p21 protein; identification of flexible regions and possible effector domains.
Dykes DC; Friedman FK; Dykes SL; Murphy RB; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1993 Dec; 11(3):443-58. PubMed ID: 8129867
[TBL] [Abstract][Full Text] [Related]
20. A glutamic acid residue at position 31 of Ras protein is essential to the signal transduction for neurite outgrowth of PC12 cells and the stimulation of GTPase activity by GAPRas.
Shirouzu M; Fujita-Yoshigaki J; Ito Y; Koide H; Nishimura S; Yokoyama S
Oncogene; 1992 Mar; 7(3):475-80. PubMed ID: 1549361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]